Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04895605 · ClinicalTrials.gov registry record
An Evaluation of Low Level Laser Light Therapy for Autistic Disorder 2
A clinical trial of Autistic Disorder, sponsored by Erchonia Corporation.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT04895605: Completed study of Autistic Disorder, sponsored by Erchonia Corporation.
NCT04895605 is a study of Autistic Disorder that has completed, run by Erchonia Corporation. The registered enrollment target is 40 participants, below the 112-participant average among 27 other Autistic Disorder trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04895605, a study of Autistic Disorder, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the Erchonia HLS Laser is effective in the treatment of irritability associated with autistic disorder in children and adolescents aged five (5) to twelve (12) years.
Primary Outcome
Primary outcome measure in this study is defined as the mean change from baseline to study endpoint in the Aberrant Behavior Checklist (ABC) Irritability Subscale score. The ABC Irritability Subscale contains 15 items relating to aggression, self-injury, tantrums, agitation and unstable mood in individuals with developmental disorders. Each item is rated from 0 (not at all a problem) to 3 (the problem is severe in degree). The individual scores are summed for a total score from 0 to 45, with hig
Conditions Studied
Interventions
- DEVICE Placebo Laser
- DEVICE Erchonia HLS Laser
Study Locations (1)
Massachusetts
- Spaulding Rehabilitation Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-11-11 |
| Est. Completion | 2022-03-17 |
What the finished NCT04895605 record still lists
NCT04895605 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 112-participant average among 27 other Autistic Disorder trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Autistic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo Laser is the first listed.
NCT04895605 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04895605 about?
NCT04895605 is a clinical study titled "An Evaluation of Low Level Laser Light Therapy for Autistic Disorder 2". The purpose of this study is to determine whether the Erchonia HLS Laser is effective in the treatment of irritability associated with autistic disorder in children and adolescents aged five (5) to twelve (12) years.
What is the current status of trial NCT04895605?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2020-11-11. Estimated completion is 2022-03-17.
What conditions does trial NCT04895605 study?
This clinical trial studies the following conditions: Autistic Disorder.
What interventions are being tested in trial NCT04895605?
The interventions under investigation include: Placebo Laser (DEVICE), Erchonia HLS Laser (DEVICE).
Who is sponsoring clinical trial NCT04895605?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04895605 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autistic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04895605's enrollment target sits among peer trials
40 21st of 27 higher than 6 of 27 other Autistic Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autistic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)
RECRUITING · NA
-
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
RECRUITING · NA
-
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
RECRUITING · NA
-
Project AFECT (Autism Family Empowerment Coaching and Training Program)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI